InvestorsHub Logo
Followers 8
Posts 560
Boards Moderated 0
Alias Born 02/21/2017

Re: Copilotdog post# 45664

Tuesday, 07/25/2017 4:34:33 PM

Tuesday, July 25, 2017 4:34:33 PM

Post# of 73682
I'm definitely bullish on this. As I mentioned in my post #45533, once volume production happens, the game changes. The 13 point plan goes full tilt. There is a lot of sales, marketing and distribution in those 13 points. #4, 6, 7, 8, 12 IMO decide the fate of the company, and based on #9, I believe it will be a success.

1. Closed Joint Venture, BIEI fully owns PBPMS [See point 2].
2. Pain Management Products will fall under Pain Management Division of BIEI, Cancer will be under Biologics division.
3. Were making everything by hand to date, moving to volume manufacture by formulations.
4. Aggressively expanding distribution network now that there is volume manufacturing in place.
5. Working with Chronic Illness Bloggers to attain reviews.
6. Initiated contact with Amazon for sales.
7. Pharmacy by mail distributor is hopeful, but needs life. It has survived 2 management changes in 2017. Needs a life-line.
8. European distributor showing interest for drop-ship.

9. Testimonies of decreasing opiod use due to products.
10. Planning on expanding pain patch size offerings to day patches etc.
11. Petition insurance agencies and medicare to cover these products in replacement of opiods.
12. Working with VA for pain patch endorsement.
13. Considering buyback of stock, in order to increase value to existing shareholders.